ADAP logo

Adaptimmune Therapeutics (ADAP)

Profile

Full Name

Adaptimmune Therapeutics plc

Ticker Symbol

ADAP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

May 6, 2015

Indexes

Not included

Website

http://www.adaptimmune.com

Employees

506

Key Details

Price

$0.27(+0.74%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$178.03M(+195.34% YoY)

Annual EPS

-$0.30(+44.44% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.27
    ADAP price is $0.27

    30-Day Relative Volume

    0.24
    ADAP 30-day relative volume is 0.24

    Price Performance

    Price Most recent change

    +0.74%
    ADAP price was up +0.74% on May 29, 2025

    Price YTD change

    -49.35%
    ADAP price is down -49.35% since January 1st

    Price 1-year change

    -72.97%
    ADAP price is down -72.97% year-on-year

    Price 3-year change

    -82.04%
    ADAP price is down -82.04% over the past 3 years

    Price Range

    Price All-time high

    $21.57
    ADAP price is currently -98.73% below its historical high of $21.57

    Price 3-year low

    $0.20
    ADAP price is currently +40.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $72.36M
    ADAP market capitalization is $72.36 million

    Market cap 3-year change

    -70.62%
    ADAP market capitalization is down -70.62% over the past 3 years

    Market cap All-time high

    $1.75B
    ADAP market capitalization is currently -95.87% below its historical high of $1.75 billion

    Market cap sector rank

    41.29%
    ADAP market capitalization is higher than 41.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.71%
    ADAP shares outstanding is up +3.71% year-on-year

    Shares Outstanding 3-Year Change

    +63.59%
    ADAP shares outstanding is up +63.59% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.18
    ADAP beta is 1.18

    200-day SMA

    $0.64
    ADAP price is currently -57.02% below its 200-day simple moving average

    50-day SMA

    $0.27
    ADAP price is currently +1.79% above its 50-day simple moving average

    RSI

    45.92
    ADAP 14-day relative strength index is 45.92

    Volume

    0.24
    ADAP 30-day relative volume is 0.24

    ATR

    $0.02
    ADAP average true range is $0.02

    10-day Historical Volatility

    49.55%
    ADAP 10-day historical volatility is 49.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $178.03M
    ADAP annual revenue is $178.03 million

    Revenue Analysts estimate

    $38.98M
    ADAP annual revenue is currently +356.68% higher than the consensus analysts' forecast

    Revenue 1-year change

    +195.34%
    ADAP annual revenue is up +195.34% year-on-year

    Revenue Sector rank

    62.23%
    ADAP annual revenue is higher than 62.23% of companies in Healthcare sector

    EPS

    EPS

    -$0.30
    ADAP annual earnings per share is -$0.30

    EPS Analysts estimate

    -$0.49
    ADAP annual earnings per share is currently -38.65% lower than the consensus analysts' forecast

    EPS 1-year change

    +44.44%
    ADAP annual earnings per share is up +44.44% year-on-year

    EPS Sector rank

    73.89%
    ADAP annual earnings per share is higher than 73.89% of companies in Healthcare sector

    Profit

    Gross profit

    $177.96M
    ADAP annual gross profit is $177.96 million

    Gross margin

    99.96%
    ADAP annual gross profit margin is 99.96%

    Operating profit

    -$52.41M
    ADAP annual operating income is -$52.41 million

    Operating margin

    -29.44%
    ADAP annual operating profit margin is -29.44%

    Net income

    -$70.81M
    ADAP annual net profit is -$70.81 million

    Net margin

    -39.78%
    ADAP annual net profit margin is -39.78%

    Expenses

    Total expenses

    $230.44M
    ADAP annual total expenses is $230.44 million

    Operating expenses

    $230.37M
    ADAP annual total operating expenses is $230.37 million

    Cost of goods sold

    $70.00K
    ADAP annual cost of goods sold is $70.00 thousand

    Selling, general & administrative expenses

    $81.31M
    ADAP annual SGA is $81.31 million

    Depreciation and amortization

    $11.22M
    ADAP annual depreciation & amortization is $11.22 million

    Interest expense

    $3.35M
    ADAP annual interest expense is $3.35 million

    Income tax

    $3.58M
    ADAP annual income tax is $3.58 million

    EBIT & EBITDA

    EBIT

    -$63.89M
    ADAP annual earnings before interest & taxes is -$63.89 million

    EBITDA

    -$52.66M
    ADAP annual EBITDA is -$52.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $245.96M
    ADAP annual total assets is $245.96 million

    Non current assets

    $57.79M
    ADAP annual long term assets is $57.79 million

    Current assets

    $188.17M
    ADAP annual total current assets is $188.17 million

    Cash and cash equivalents

    $91.14M
    ADAP annual cash & cash equivalents is $91.14 million

    Accounts receivable

    $1.45M
    ADAP annual accounts receivable is $1.45 million

    Inventory

    $7.32M
    ADAP annual inventory is $7.32 million

    Liabilities

    Total liabilities

    $234.11M
    ADAP annual total liabilities is $234.11 million

    Long term liabilities

    $169.59M
    ADAP annual total long term liabilities is $169.59 million

    Current liabilities

    $64.53M
    ADAP annual total current liabilities is $64.53 million

    Accounts payable

    $8.69M
    ADAP annual accounts payable is $8.69 million

    Debt

    Total debt

    $74.21M
    ADAP annual total debt is $74.21 million

    Total debt 1-year change

    +194.07%
    ADAP annual total debt is up +194.07% year-on-year

    Long term debt

    $69.50M
    ADAP annual long term debt is $69.50 million

    Short term debt

    $4.71M
    ADAP annual short term debt is $4.71 million

    Equity & Capital

    Shareholders equity

    $11.85M
    ADAP annual stockholders equity is $11.85 million

    Book value

    $11.85M
    ADAP annual book value is $11.85 million

    Retained earnings

    -$1.09B
    ADAP annual retained earnings is -$1.09 billion

    Working capital

    $123.64M
    ADAP annual working capital is $123.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$73.21M
    ADAP annual cash flow from operations is -$73.21 million

    Cash from operations 1-year change

    +48.04%
    ADAP annual cash flow from operations is up +48.04% year-on-year

    Cash from investing

    -$58.95M
    ADAP annual cash flow from investing activities is -$58.95 million

    Cash from investing 1-year change

    -133.39%
    ADAP annual cash flow from investing activities is down -133.39% year-on-year

    Cash from financing

    $78.75M
    ADAP annual cash flow from financing activities is $78.75 million

    Cash from financing 1-year change

    +8848.75%
    ADAP annual cash flow from financing activities is up +8848.75% year-on-year

    CAPEX

    CAPEX

    $2.72M
    ADAP annual capital expenditures is $2.72 million

    CAPEX 1-year change

    -44.26%
    ADAP annual capital expenditures is down -44.26% year-on-year

    Free Cash Flow

    Free cash flow

    -$75.93M
    ADAP annual free cash flow is -$75.93 million

    Free cash flow 1-year change

    +47.91%
    ADAP annual free cash flow is up +47.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    99.96%
    ADAP annual gross profit margin is 99.96%

    Operating margin

    -29.44%
    ADAP annual operating profit margin is -29.44%

    Net margin

    -39.78%
    ADAP annual net profit margin is -39.78%

    ROA & ROE

    ROA

    -26.79%
    ADAP annual return on assets is -26.79%

    ROE

    -275.74%
    ADAP annual return on equity is -275.74%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ADAP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ADAP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -1.93
    ADAP price to book ratio is -1.93

    PB ratio Sector rank

    6.98%
    ADAP price to book ratio is higher than 6.98% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.40
    ADAP price to sales ratio is 0.40

    PS ratio Sector rank

    12.45%
    ADAP price to sales ratio is higher than 12.45% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $80.01M
    ADAP enterprise value is $80.01 million

    Enterprise value Sector rank

    44.67%
    ADAP enterprise value is higher than 44.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.59
    ADAP EV/EBITDA is -1.59

    EV/EBITDA Sector rank

    39.39%
    ADAP EV/EBITDA is higher than 39.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.92
    ADAP annual current ratio is 2.92

    Quick ratio

    2.80
    ADAP annual quick ratio is 2.80

    Leverage

    Debt to equity

    4.24
    ADAP annual debt to equity ratio is 4.24

    Interest coverage ratio

    -19.08
    ADAP annual interest coverage ratio is -19.08

    Risk & Stability

    Piotroski F-Score

    -
    ADAP piotroski f-score value is unknown

    Altman Z-Score

    -5.57
    ADAP altman z-score is -5.57

    Analyst ratings

    Recent major analysts updates

    Apr 1, 25 HC Wainwright & Co.
    Buy
    Mar 26, 25 Guggenheim
    Buy
    Mar 21, 25 Wells Fargo
    Equal-Weight
    Mar 21, 25 Scotiabank
    Sector Outperform
    Nov 27, 24 Mizuho
    Outperform
    Nov 19, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Guggenheim
    Buy
    Nov 14, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 HC Wainwright & Co.
    Buy
    Aug 5, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ADAP included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks with high beta
    UK stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Adaptimmune Therapeutics?
    • Does Adaptimmune Therapeutics pay dividends?
    • What sector is Adaptimmune Therapeutics in?
    • What industry is Adaptimmune Therapeutics in?
    • What country is Adaptimmune Therapeutics based in?
    • When did Adaptimmune Therapeutics go public?
    • Is Adaptimmune Therapeutics in the S&P 500?
    • Is Adaptimmune Therapeutics in the NASDAQ 100?
    • Is Adaptimmune Therapeutics in the Dow Jones?
    • When was Adaptimmune Therapeutics's last earnings report?
    • When does Adaptimmune Therapeutics report earnings?
    • Should I buy Adaptimmune Therapeutics stock now?

    What is the ticker symbol for Adaptimmune Therapeutics?

    The ticker symbol for Adaptimmune Therapeutics is NASDAQ:ADAP

    Does Adaptimmune Therapeutics pay dividends?

    No, Adaptimmune Therapeutics does not pay dividends

    What sector is Adaptimmune Therapeutics in?

    Adaptimmune Therapeutics is in the Healthcare sector

    What industry is Adaptimmune Therapeutics in?

    Adaptimmune Therapeutics is in the Biotechnology industry

    What country is Adaptimmune Therapeutics based in?

    Adaptimmune Therapeutics is headquartered in United Kingdom

    When did Adaptimmune Therapeutics go public?

    Adaptimmune Therapeutics's initial public offering (IPO) was on May 6, 2015

    Is Adaptimmune Therapeutics in the S&P 500?

    No, Adaptimmune Therapeutics is not included in the S&P 500 index

    Is Adaptimmune Therapeutics in the NASDAQ 100?

    No, Adaptimmune Therapeutics is not included in the NASDAQ 100 index

    Is Adaptimmune Therapeutics in the Dow Jones?

    No, Adaptimmune Therapeutics is not included in the Dow Jones index

    When was Adaptimmune Therapeutics's last earnings report?

    Adaptimmune Therapeutics's most recent earnings report was on May 13, 2025

    When does Adaptimmune Therapeutics report earnings?

    The next expected earnings date for Adaptimmune Therapeutics is Aug 12, 2025

    Should I buy Adaptimmune Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page